The results of Phase III clinical trials with telaprevir and boceprevir presented at the Liver Meeting 2010: a new standard of care for hepatitis C virus genotype 1 infection, but with issues still pending.

Gastroenterology

National Reference Center for Viral Hepatitis B, C and Delta, Department of Virology, Hôpital Henri Mondor, Université Paris-Est, Créteil, France.

Published: March 2011

Download full-text PDF	Source
http://dx.doi.org/10.1053/j.gastro.2011.01.028	DOI Listing

Publication Analysis

phase iii

iii clinical

clinical trials

trials telaprevir

telaprevir boceprevir

boceprevir presented

presented liver

liver meeting

meeting 2010

2010 standard

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!